<SEC-DOCUMENT>0001140361-24-036404.txt : 20240808
<SEC-HEADER>0001140361-24-036404.hdr.sgml : 20240808
<ACCEPTANCE-DATETIME>20240808161443
ACCESSION NUMBER:		0001140361-24-036404
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20240806
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240808
DATE AS OF CHANGE:		20240808

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GYRE THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001124105
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				562020050
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-51173
		FILM NUMBER:		241188526

	BUSINESS ADDRESS:	
		STREET 1:		12770 HIGH BLUFF DRIVE, SUITE 150
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
		BUSINESS PHONE:		(619) 949-3681

	MAIL ADDRESS:	
		STREET 1:		12770 HIGH BLUFF DRIVE, SUITE 150
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CATALYST BIOSCIENCES, INC.
		DATE OF NAME CHANGE:	20150820

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TARGACEPT INC
		DATE OF NAME CHANGE:	20000919
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ef20033805_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2023" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:cef="http://xbrl.sec.gov/cef/2023" xmlns:gyre="http://ir.catalystbiosciences.com/20240806" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions
         Document created using Broadridge PROfile 24.6.2.5244
         Copyright 1995 - 2024 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html"/>
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_ac35e0de7f314a7bbe8ec32436c8b888" contextRef="c20240806to20240806" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_aba2505f229648b989bdd47d4d1785ad" contextRef="c20240806to20240806">0001124105</ix:nonNumeric><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_a48ae1d2275e4cb08bfd46c5efcde35b" contextRef="c20240806to20240806">NASDAQ</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="gyre-20240806.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="c20240806to20240806"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001124105</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-08-06</xbrli:startDate><xbrli:endDate>2024-08-06</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
<div style="line-height: initial;">
  <div><span style="font-family: 'Times New Roman';"> </span></div>

  <div>
    <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/>
    <div>
      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">UNITED STATES</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">WASHINGTON, D.C. 20549</div>

      <div style="font-family: 'Times New Roman';">
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

      <div style="font-family: 'Times New Roman';"><br/>
      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_d4bcfa713a6244d3870d8a0c1d49e8ec" contextRef="c20240806to20240806">8-K</ix:nonNumeric></div>

      <div style="font-family: 'Times New Roman';"><br/>
      </div>

      <div style="font-family: 'Times New Roman';">
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934</div>

      <div style="font-family: 'Times New Roman';"><br/>
      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Date of report (Date of earliest event reported): <span style="font-weight: bold;"><ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_481c5670179d4a668ea4f0446e1015e8" contextRef="c20240806to20240806" format="ixt:date-monthname-day-year-en">August 6, 2024</ix:nonNumeric></span></div>

      <div style="font-family: 'Times New Roman';"><br/>
      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 24pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_ddfafff6c463426cbead8059ea0e0587" contextRef="c20240806to20240806">Gyre Therapeutics, Inc.</ix:nonNumeric><br/>
      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(Exact name of registrant as specified in its charter)</div>

      <div style="font-family: 'Times New Roman';"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 33%; vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: center; color: rgb(0, 0, 0); font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_611f35cbf21546f69be1b60b814a179f" contextRef="c20240806to20240806" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 34%; vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: center; color: rgb(0, 0, 0); font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_4a2d6c0219384a5da162b253edc867c7" contextRef="c20240806to20240806">000-51173</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 33%; vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: center; color: rgb(0, 0, 0); font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_fabad11441cc47feb521a82080a95bba" contextRef="c20240806to20240806">56-2020050</ix:nonNumeric><br/>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 33%; vertical-align: top; font-family: 'Times New Roman';">
              <div style="text-align: center; color: rgb(0, 0, 0); font-size: 10pt;">(State or other jurisdiction of incorporation)</div>
            </td>

    <td style="width: 34%; vertical-align: top; font-family: 'Times New Roman';">
              <div style="text-align: center; color: rgb(0, 0, 0); font-size: 10pt;">(Commission File Number)</div>
            </td>

    <td style="width: 33%; vertical-align: top; font-family: 'Times New Roman';">
              <div style="text-align: center; color: rgb(0, 0, 0); font-size: 10pt;">(IRS Employer Identification No.)</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman';"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 49%; vertical-align: bottom;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_5f41171208514f7ba99948bee88a2a90" contextRef="c20240806to20240806">12770 High Bluff Drive</ix:nonNumeric><br/>
              </div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine2" id="Fact_c6b50b2050bd41e6848813273234bb89" contextRef="c20240806to20240806">Suite 150</ix:nonNumeric><br/>
              </div>
              <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_af36167fe088425f8d453a4358809f15" contextRef="c20240806to20240806">San Diego</ix:nonNumeric>,
                <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_521cd7eedebc4c9980c6c3ddbe08e47a" contextRef="c20240806to20240806">CA</ix:nonNumeric></div>
            </td>

    <td style="width: 2%; vertical-align: bottom;" colspan="1"><br/>
            </td>

    <td style="width: 49%; vertical-align: bottom; font-family: 'Times New Roman';">
              <div style="text-align: center; color: rgb(0, 0, 0); font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_7d0528ba37c54ca99eaaca60f1962972" contextRef="c20240806to20240806">92130</ix:nonNumeric><br/>
              </div>
            </td>

  </tr>

  <tr>

    <td style="width: 49%; vertical-align: top; font-family: 'Times New Roman';">
              <div style="text-align: center; color: rgb(0, 0, 0); font-size: 10pt;">(Address of principal executive offices)</div>
            </td>

    <td style="width: 2%; vertical-align: top; font-family: 'Times New Roman';" colspan="1"><br/>
            </td>

    <td style="width: 49%; vertical-align: top; font-family: 'Times New Roman';">
              <div style="text-align: center; color: rgb(0, 0, 0); font-size: 10pt;">(Zip Code)</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman';"><br/>
      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Registrant&#8217;s telephone number, including area code: <span style="font-size: 10pt; font-weight: bold;">(<ix:nonNumeric name="dei:CityAreaCode" id="Fact_ddcc513b8d604fb1a3bf00ca5b7e4df2" contextRef="c20240806to20240806">619</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_bb89480ce0904a68bab8799f80fd4fed" contextRef="c20240806to20240806">949-3681</ix:nonNumeric></span></div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">N/A</div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(Former name or former address, if changed since last report.)</div>

      <div style="font-family: 'Times New Roman';"><br/>
      </div>

      <div style="font-family: 'Times New Roman';">
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

      <div style="font-family: 'Times New Roman';"><br/>
      </div>

      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
        following provisions (see General Instruction A.2. below):</div>

      <div style="font-family: 'Times New Roman';"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_e0159aa2fe4f4ece96a564c03c48afed" contextRef="c20240806to20240806" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman';">
              <div style="color: rgb(0, 0, 0); font-size: 10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman';"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_3039ddab98314cabb99f3046336ab7ee" contextRef="c20240806to20240806" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman';">
              <div style="color: rgb(0, 0, 0); font-size: 10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman';"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_1b883be29c59427c9a0805c407889202" contextRef="c20240806to20240806" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman';">
              <div style="color: rgb(0, 0, 0); font-size: 10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman';"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 18pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_4ab3b09267904dc78f40ce0dc2cdd0d2" contextRef="c20240806to20240806" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
            </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman';">
              <div style="color: rgb(0, 0, 0); font-size: 10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman';"><br/>
      </div>

      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

      <div style="font-family: 'Times New Roman';"><br/>
      </div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 32%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; white-space: nowrap;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-size: 10pt;">Title of each class</div>
            </td>

    <td style="width: 2%; vertical-align: bottom; font-family: 'Times New Roman';"><br/>
            </td>

    <td style="width: 32%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman';">
              <div style="text-align: center; color: rgb(0, 0, 0); font-size: 10pt;">Trading Symbol(s)</div>
            </td>

    <td style="width: 2%; vertical-align: bottom; font-family: 'Times New Roman';"><br/>
            </td>

    <td style="width: 32%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman'; white-space: nowrap;">
              <div style="text-align: center; color: rgb(0, 0, 0); font-size: 10pt;">Name of each exchange on which registered</div>
            </td>

  </tr>

  <tr>

    <td style="width: 32%; vertical-align: top; font-family: 'Times New Roman';">
              <div style="text-align: center; color: rgb(0, 0, 0); font-size: 10pt;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_501596c5f0d34a489a8ebc52c5c0b24c" contextRef="c20240806to20240806">Common Stock</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 2%; vertical-align: top; font-family: 'Times New Roman';"><br/>
            </td>

    <td style="width: 32%; vertical-align: top; font-family: 'Times New Roman';">
              <div style="text-align: center; color: rgb(0, 0, 0); font-size: 10pt;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_82ec86713e0c4eefba3433ee6e35e9c5" contextRef="c20240806to20240806">GYRE</ix:nonNumeric><br/>
              </div>
            </td>

    <td style="width: 2%; vertical-align: top; font-family: 'Times New Roman';"><br/>
            </td>

    <td style="width: 32%; vertical-align: top; font-family: 'Times New Roman';">
              <div style="text-align: center; color: rgb(0, 0, 0); font-size: 10pt;"><span style="-sec-ix-hidden:Fact_a48ae1d2275e4cb08bfd46c5efcde35b">The Nasdaq Capital Market</span><br/>
              </div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman';"><br/>
      </div>

      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this
        chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</div>

      <div style="font-family: 'Times New Roman';"><br/>
      </div>

      <div style="text-align: justify; text-indent: -324pt; margin-left: 324pt; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_afaed60caf1647e7a94c82013b657f0f" contextRef="c20240806to20240806" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></div>

      <div style="font-family: 'Times New Roman';"><br/>
      </div>

      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any
        new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</div>

      <div style="font-family: 'Times New Roman';"><br/>
      </div>

      <div style="font-family: 'Times New Roman';">
        <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/></div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 54pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item&#8201;5.02</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman';">
              <div style="color: rgb(0, 0, 0); font-size: 10pt; font-weight: bold;"> Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</div>
            </td>

  </tr>


</table>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"> <br/>
      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;">Appointment of Director</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-style: italic;"> <br/>
      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">On August 6, 2024, the Board of Directors (the &#8220;Board&#8221;) of Gyre Therapeutics, Inc. (the &#8220;Company&#8221;) appointed David Epstein, Ph.D. as a Class II director to serve until
        the Company&#8217;s 2026 Annual Meeting of Stockholders and until his successor is duly elected and qualified. Dr. Epstein was also appointed as a member of the Board&#8217;s Audit Committee and Compensation Committee.</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Dr. Epstein, age 65, is a co-founder of PairX Bio Pte. Ltd., a biopharmaceutical company, where he has served as a director since June 2022 and as President and Chief
        Executive Officer since September 2023. Dr. Epstein is also the co-founder of Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), where he served as President and Chief Executive Officer from September 2016 to September 2023. He also served as
        director of Black Diamond Therapeutics from September 2016 until June 2024. From January 2019 to June 2023, Dr. Epstein served as an Associate Professor in the Cancer and Stem Cell Biology Program at Duke-NUS Medical School. From April 2014 to
        December 2018, Dr. Epstein held various positions, including Vice Dean, Innovation &amp; Entrepreneurship and Associate Professor in Cancer and Stem Biology, at Duke-NUS Medical School, Singapore, where he founded and built Duke-NUS&#8217;s Center for
        Technology &amp; Development. From June 2010 to March 2013, Dr. Epstein was Senior Vice President, Chief Scientific Officer and Site Head for OSI Pharmaceuticals, Inc. (&#8220;OSI&#8221;), a pharmaceutical company acquired by Astellas Pharma, Inc. He also
        served as Senior Vice President and Chief Scientific Officer, Oncology, at OSI from 2006 to 2010. Before joining OSI, from 2001 to 2006, Dr. Epstein served as Vice President, Biology, and from 2000 to 2003, as co-founder and director at Archemix
        Corporation, a biotechnology company. Dr. Epstein served as a member of the board of directors at MetaStat, Inc., a precision medicine biotechnology company, from April 2013 to April 2015. Dr. Epstein earned a B.S. in Chemistry from Lewis &amp;
        Clark College and a Ph.D. in Biochemistry from Brandeis University. Dr. Epstein completed a joint post-doctoral fellowship, leading a collaboration in protein structure, function and NMR dynamics between the labs of Steven Benkovic at Penn State
        and Peter Wright at The Scripps Research Institute in La Jolla, California.</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">In connection with his appointment to the Board, Dr. Epstein will be entitled to receive compensation in accordance with the Company&#8217;s non-employee director compensation
        policy as described in the Company&#8217;s Definitive Proxy Statement filed on April 29, 2024. Dr. Epstein is also entering into the Company&#8217;s standard form of indemnification agreement, a form of which was previously filed as Exhibit 10.3 to the
        Company&#8217;s Current Report on Form 8-K filed on October 30, 2023.</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">There are no arrangements or understandings between Dr. Epstein and any other person pursuant to which he was appointed as director of the Company; there are no family
        relationships between Dr. Epstein and any director or executive officer of the Company; and Dr. Epstein is not a party to any transactions of the type that would require disclosure under Item 404(a) of Regulation S-K.</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 54pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item&#8201;7.01</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman';">
              <div style="color: rgb(0, 0, 0); font-size: 10pt; font-weight: bold;"> Regulation FD Disclosure.</div>
            </td>

  </tr>


</table>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">A copy of the Company&#8217;s press release announcing the foregoing appointment is furnished hereto as Exhibit 99.1.</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">The information in this Item 7.01 (including Exhibit 99.1) shall not be deemed &#8220;filed&#8221; for purposes of Section 18 of the Exchange Act, or otherwise subject to the
        liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as expressly set forth by specific reference in such a filing.</div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 54pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item&#8201;8.01</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman';">
              <div style="color: rgb(0, 0, 0); font-size: 10pt; font-weight: bold;">Other Events.</div>
            </td>

  </tr>


</table>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
      </div>

      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Also on August 6, 2024, the Board appointed Rodney Nussbaum as chair of the Audit Committee.</div>

      <div style="text-align: left; font-family: 'Times New Roman';"><br/>
      </div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">


  <tr>

    <td style="width: 54pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item&#8201;9.01</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-family: 'Times New Roman';">
              <div style="color: rgb(0, 0, 0); font-size: 10pt; font-weight: bold;"> Financial Statements and Exhibits.</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman';"><br/>
      </div>

      <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">(d) <span style="font-size: 10pt; font-style: italic;">Exhibits</span>. The following exhibits are being furnished herewith:</div>

      <div style="text-align: justify;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> </span><span style="font-family: 'Times New Roman';"><br/>
        </span></div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">


  <tr>

    <td style="width: 17.83%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman';">
              <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt; font-weight: bold;">Exhibit Number</div>
            </td>

    <td style="width: 1%; vertical-align: bottom; font-family: 'Times New Roman';">&#160;</td>

    <td style="width: 81%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman';">
              <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt; font-weight: bold;">Exhibit Title or Description</div>
            </td>

  </tr>

  <tr>

    <td style="width: 17.83%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>

    <td style="width: 81%; vertical-align: top; font-family: 'Times New Roman';">&#160;</td>

  </tr>

  <tr>

    <td style="width: 17.83%; vertical-align: top; font-family: 'Times New Roman';">
              <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;"><a href="ef20033805_ex99-1.htm">99.1</a></div>
            </td>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">&#160;</td>

    <td style="width: 81%; vertical-align: top;">
              <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Press Release, dated August 8, 2024</span></div>
            </td>

  </tr>

  <tr>

    <td style="width: 17.83%; vertical-align: top; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">&#160;</td>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">&#160;</td>

    <td style="width: 81%; vertical-align: top; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">&#160;</td>

  </tr>

  <tr>

    <td style="width: 17.83%; vertical-align: top; font-family: 'Times New Roman';">
              <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">104</div>
            </td>

    <td style="width: 1%; vertical-align: top; font-family: 'Times New Roman'; color: rgb(0, 0, 0);">&#160;</td>

    <td style="width: 81%; vertical-align: top; font-family: 'Times New Roman';">
              <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman';"><br/>
      </div>

      <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
        <div class="BRPFPageBreak" style="page-break-after: always;">
          <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

      </div>

      <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SIGNATURE</div>

      <div style="text-align: center;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> </span><span style="font-family: 'Times New Roman';"><br/>
        </span></div>

      <div style="text-align: justify; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the
        undersigned hereunto duly authorized.</div>

      <div style="text-align: justify;"><span style="font-size: 10pt; font-family: 'Times New Roman'; color: rgb(0, 0, 0);"> </span><span style="font-family: 'Times New Roman';"><br/>
        </span></div>

      <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman';"><br/>
            </td>

    <td style="vertical-align: top; font-family: 'Times New Roman';" colspan="2">
              <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt; font-weight: bold;">GYRE THERAPEUTICS, INC.</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman';"><br/>
            </td>

    <td style="vertical-align: top; font-family: 'Times New Roman';" colspan="2"><br/>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman';">
              <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Date: <span style="font-size: 10pt; font-weight: bold;">August 8, 2024</span></div>
            </td>

    <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman';">
              <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">By:</div>
            </td>

    <td style="width: 45%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-family: 'Times New Roman';">
              <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">/s/ Ruoyu Chen</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman';"><br/>
            </td>

    <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman';">
              <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Name:</div>
            </td>

    <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman';">
              <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Ruoyu Chen</div>
            </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-family: 'Times New Roman';"><br/>
            </td>

    <td style="width: 5%; vertical-align: top; font-family: 'Times New Roman';">
              <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Title:</div>
            </td>

    <td style="width: 45%; vertical-align: top; font-family: 'Times New Roman';">
              <div style="text-align: left; color: rgb(0, 0, 0); font-size: 10pt;">Chief Financial Officer</div>
            </td>

  </tr>


</table>
      <div style="font-family: 'Times New Roman';"><br/>
      </div>

      <div style="font-family: 'Times New Roman';"><br/>
      </div>

      <div style="font-family: 'Times New Roman';">
        <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

    </div>

  </div>

  <div><span style="font-family: 'Times New Roman';"> </span></div>

</div>
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ef20033805_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions. Inc.
         Document created using Broadridge PROfile 24.6.2.5244
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
    <div style="text-align: right;"> <font style="font-weight: bold;">Exhibit 99.1</font><br>
    </div>
    <div> <br>
    </div>
    <div> <br>
    </div>
    <div>
      <div style="text-align: left;"><img width="205" height="43" src="image0.jpg"></div>
      <div>&#160;</div>
      <div><br>
      </div>
      <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Gyre Therapeutics Announces Appointment of David M. Epstein, Ph.D., to Board of Directors</div>
      <div>&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">SAN DIEGO, Aug. 8, 2024 (GLOBE NEWSWIRE) &#8211; Gyre Therapeutics (&#8220;<a name="z_9kR3WTr244457OTBs"></a>Gyre&#8221;) (Nasdaq: <a name="z_9kMHG5YVt466679QVDu"></a>GYRE), a
        self-sustainable, commercial-stage biotechnology company with clinical development programs focusing on a variety of chronic organ diseases, today announced the appointment of David M. Epstein, Ph.D., to Gyre&#8217;s Board of Directors (the &#8220;Board&#8221;),
        effective August 6, 2024. Dr. Epstein will serve as a member of the Audit Committee of the Board and as member of the <a name="z_9kR3WTr26645DQFwyrq5tv406VR874COAw"></a>Compensation Committee of the Board.</div>
      <div>&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;We are thrilled to welcome David to the <a name="z_9kR3WTr266468OTBsDIosw"></a>Gyre Board,&#8221; said Han Ying, Ph.D., <a name="z_9kR3WTr26645BO8ljhIV2izH696aWuywt9K9cqY"></a>Chief

        Executive Officer of Gyre Therapeutics. &#8220;His extensive global experience in biotech companies across the U.S. and Asia will be instrumental to Gyre as we advance our robust pipeline of clinical and pre-clinical assets forward.&#8221;</div>
      <div>&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;I am delighted to join Gyre&#8217;s Board and to work with the company as it continues to advance novel therapies for fibrotic diseases,&#8221; said Dr. Epstein. &#8220;I look forward to
        supporting Gyre as it continues to develop its global therapeutic pipeline.&#8221;</div>
      <div>&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Dr. Epstein is a co-founder of <a name="z_9kR3WTr26646EdEewm1Dxff1"></a>PairX Bio Pte. Ltd., a <a name="z_9kR3WTr26646GiPrqeo36xifx2o"></a>Singapore-based biotechnology
        company that is developing next-generation cancer-selective biologics, where he currently serves as director, President and Chief Executive Officer. Dr. Epstein co-founded and served as President and <a name="z_9kR3WTr26645AN8ljhIV2izH696aWuywt9K9XY4"></a>Chief Executive Officer of Black Diamond Therapeutics (Nasdaq: BDTX), leading the company through its <a name="z_9kR3WTr26646DW8j4sqFRHIJa7E"></a>January 2020 IPO and clinical proof-of-concept
        of its <a name="z_9kR3WTr266467Lily5FsCzyfN8"></a>EFGR MasterKey inhibitor in 2023. Prior to Black Diamond, Dr. Epstein was <a name="z_9kR3WTr26647AeSgdFAeo"></a>Vice Dean, <a name="z_9kR3WTr26646BTKwy7ut2y4VQCH32G634CQPG7G"></a>Innovation &amp;
        Entrepreneurship and <a name="z_9kR3WTr266459KH63ojiuzWeAzq4JGG"></a>Associate Professor at <a name="z_9kR3WTr26645FTM0lPAG9MkppislXt6EC"></a>Duke-NUS Medical School in Singapore, and prior to that he served as <a name="z_9kR3WTr26645CP8ljhWOlouA6tusZXvzxuALAlT"></a>Chief Scientific Officer of OSI Pharmaceuticals (&#8220;OSI&#8221;), which was acquired by Astellas Pharma for over $4 billion in 2010.&#160; Before his time at OSI, Dr. Epstein was a scientific founder and
        director at Archemix Corp., where he developed avacincaptad pegol (<a name="z_9kR3WTr26646CUWzsAuy"></a>Izervay&#8482;), an anti-C5 aptamer for treatment of geographic atrophy secondary to age-related macular degeneration. <a name="z_9kMHG5YVt48868EWY1uCw0"></a>Izervay&#8482; was acquired by Iveric Bio and sold to Astellas Pharma Inc. for $5.9 billion in 2023.</div>
      <div>&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">About Gyre Therapeutics</div>
      <div>&#160;</div>
      <div style="text-align: justify; font-family: 'Times New Roman'; font-size: 10pt;">Gyre <a name="z_9kR3WTr266478aPhspotzF4oz"></a>Therapeutics is a biopharmaceutical company headquartered in San Diego, CA, with a primary focus on the development and
        commercialization of F351 (<a name="z_9kR3WTr26646ARUxr30vmt4v"></a>Hydronidone) for the treatment of NASH-associated fibrosis in the <a name="z_9kR3WTr266479cByVDuw"></a>U.S. Gyre&#8217;s development strategy for F351 in NASH is based on the company&#8217;s
        experience in NASH rodent model mechanistic studies and CHB-induced liver fibrosis clinical studies. Gyre is also advancing a diverse pipeline in the PRC through its indirect controlling interest in <a name="z_9kR3WTr266469PTBsRPhs5pgl4K9tmwF"></a>Gyre

        Pharmaceuticals, including ETUARY therapeutic expansions, F573, F528, and F230.</div>
      <div>&#160;</div>
      <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
        <div style="page-break-after: always;" class="BRPFPageBreak">
          <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      </div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Forward-Looking Statements</div>
      <div>&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">This press release contains &#8220;forward-looking statements&#8221; within the meaning of the &#8220;safe harbor&#8221; provisions of the Private Securities Litigation Reform Act of 1995, which
        statements are subject to substantial risks and uncertainties and are based on estimates and assumptions. All statements, other than statements of historical facts included in this press release, are forward-looking statements, including statements
        concerning: expectations regarding Gyre&#8217;s research and development efforts, expectations regarding future product sales, and Gyre&#8217;s business strategies. In some cases, you can identify forward-looking statements by terms such as &#8220;may,&#8221; &#8220;might,&#8221;
        &#8220;will,&#8221; &#8220;objective,&#8221; &#8220;intend,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;can,&#8221; &#8220;would,&#8221; &#8220;expect,&#8221; &#8220;believe,&#8221; &#8220;design,&#8221; &#8220;estimate,&#8221; &#8220;predict,&#8221; &#8220;potential,&#8221; &#8220;plan&#8221; or the negative of these terms, and similar expressions intended to identify forward-looking statements.
        These statements reflect Gyre&#8217;s plans, estimates, and expectations, as of the date of this press release. These statements involve known and unknown risks, uncertainties and other factors that could cause Gyre&#8217;s actual results to differ materially
        from the forward-looking statements expressed or implied in this press release, including without limitation: Gyre&#8217;s ability to execute on its clinical development strategies; positive results from a clinical trial may not necessarily be predictive
        of the results of future or ongoing clinical trials; the timing or likelihood of regulatory filings and approvals; competition from competing products; the impact of general economic, health, industrial or political conditions in the United States
        or internationally; the sufficiency of Gyre&#8217;s capital resources and its ability to raise additional capital. Additional risks and factors are identified under &#8220;<a name="z_9kR3WTr26646FgOwzN8cw98D"></a>Risk Factors&#8221; in Gyre&#8217;s <a name="z_9kR3WTr266458JCw4skcQv69FD8aWFEPRl"></a>Annual Report on Form 10-K for the year ended December 31, 2023, filed on March 27, 2024, and subsequent reports filed with the Securities and Exchange Commission.</div>
      <div>&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Gyre expressly disclaims any obligation to update any forward-looking statements whether as a result of new information, future events or otherwise, except as required by
        law.</div>
      <div>&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">For Investors:</div>
      <div>&#160;</div>
      <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Stephen Jasper</div>
      <div>&#160;</div>
      <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><u>stephen@gilmartinir.com</u></div>
      <div>&#160;</div>
      <div>&#160;
        <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
    </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>gyre-20240806.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.6.2.5244 Broadridge-->
<xs:schema targetNamespace="http://ir.catalystbiosciences.com/20240806" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:gyre="http://ir.catalystbiosciences.com/20240806" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:srt-types="http://fasb.org/srt-types/2023">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="gyre-20240806_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="gyre-20240806_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2023" schemaLocation="https://xbrl.sec.gov/currency/2023/currency-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2023" schemaLocation="https://xbrl.sec.gov/exch/2023/exch-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2023" schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2023" schemaLocation="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>gyre-20240806_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.6.2.5244 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract" xml:lang="en-US" id="dei_CoverAbstract">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract" xlink:title="label: CoverAbstract to dei_CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType" xml:lang="en-US" id="dei_DocumentType">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType" xlink:title="label: DocumentType to dei_DocumentType" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications" xml:lang="en-US" id="dei_WrittenCommunications">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications" xlink:title="label: WrittenCommunications to dei_WrittenCommunications" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial" xml:lang="en-US" id="dei_SolicitingMaterial">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer" xml:lang="en-US" id="dei_PreCommencementTenderOffer">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag" xml:lang="en-US" id="dei_AmendmentFlag">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag" xlink:title="label: AmendmentFlag to dei_AmendmentFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus" xml:lang="en-US" id="dei_DocumentFiscalYearFocus">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate" xml:lang="en-US" id="dei_DocumentPeriodEndDate">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName" xml:lang="en-US" id="dei_EntityRegistrantName">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey" xml:lang="en-US" id="dei_EntityCentralIndexKey">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber" xml:lang="en-US" id="dei_EntityFileNumber">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber" xlink:title="label: EntityFileNumber to dei_EntityFileNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1" xml:lang="en-US" id="dei_EntityAddressAddressLine1">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2" xml:lang="en-US" id="dei_EntityAddressAddressLine2">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3" xml:lang="en-US" id="dei_EntityAddressAddressLine3">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown" xml:lang="en-US" id="dei_EntityAddressCityOrTown">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince" xml:lang="en-US" id="dei_EntityAddressStateOrProvince">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry" xml:lang="en-US" id="dei_EntityAddressCountry">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode" xml:lang="en-US" id="dei_EntityAddressPostalZipCode">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode" xml:lang="en-US" id="dei_CityAreaCode">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode" xlink:title="label: CityAreaCode to dei_CityAreaCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber" xml:lang="en-US" id="dei_LocalPhoneNumber">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle" xml:lang="en-US" id="dei_Security12bTitle">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle" xlink:title="label: Security12bTitle to dei_Security12bTitle" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag" xml:lang="en-US" id="dei_NoTradingSymbolFlag">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol" xml:lang="en-US" id="dei_TradingSymbol">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol" xlink:title="label: TradingSymbol to dei_TradingSymbol" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName" xml:lang="en-US" id="dei_SecurityExchangeName">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>gyre-20240806_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.6.2.5244 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="gyre-20240806.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !G >H# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBBB@ K
MY=_:>_;"^!W[)7AF+7?BQXE:/5]3M[B7PQX%T**/4_&OBN2W^5QI.DF>WBM[
M))<13ZUK%WIFAVTI$,VHK<O%!)G?MH?M6>&?V0?@CK?Q,U>"WU?Q+=RKX?\
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M=%?@W\2/CE\9OC9K)OOBU\7OB9\5]<O+LRQMX]\=^)_&EV;N=G;;8VNMZGJ
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MY/A*G^W*,/9XBG@)RC[?#YA0BY1J8:I!6^M4=*52$*\J>'E&FS_29HK\Y?\
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M_P""1/\ ;G_",?\ #/VD_P#"2?V5_;W_  CW_"W_ (F?VY_88O!IYUG^R?\
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MUX3IYBJM+&X;AS$9E2H9?0JTL0O;+ XNGBLQGA</64:=3*<5AHTX_4Y48O\
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M@VV2^)_%]S/<Z!8:#873B36+C1[S6M3DMH)DTK3KR:6#/WY_P5"_X)>^"?\
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M%A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% ' _%3X8^"/C5\-O'/PD^)6@V?B?P#\1O"^L^#_%N@WT:O;ZEHFN64MC
M>P@LK&"X2.7SK.[BVW%E>107EL\=Q!%(O^79_P %#_V!/BU_P3Q_:#U_X/?$
M&PU34_!E]/>:O\'?BE+8B+1/B?X$^T%+34;>ZMS)8V_BG1PT6G>-/#9EBO\
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MYJ<%_';W"C+V>H0(PN],OXQ@RZ?J4%K>Q @RP(",^AU^9'[)O_!-+PI^R/\
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M'Q6\/R6#?8+S3[OQ/)I]W-JU]I]Q#*UY;^,]'U#7[B^6>UO/$%J"IMOTL?\
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M$8PA"*48PA%*,8QBK*,8I)))625D%%%%04%?S?\ _!23_E*S^QM_V!?V=_\
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M3[#I,+FXO[K8L;ZCK6JW<ESJVO:K*B(D^JZS?7VHS(B))<LD:*L6O? _X/\
MBKXA:'\6/%?PV\'^*OB/X7TR;1_"?C'Q/H=EXBUOP?IMU-'<WUMX/N=9BO?^
M$4_M*>&"759O#RZ;/JKV]L=1EN?LT C**_G6IFN9UL9B<QK9CCZN88UUGC,=
M4Q>(GC,6\2FL1]9Q,JCK5_;IM5O:SE[5-J?,FS^PL'E>69?@<)E> R[ X++<
M!3HT<#E^$PF'PV!P5+#V]A2PF$HTX4,/3HV7LH4:<(T[+D2L>J4445P'>%%%
M% !1110 5^$W[>'[/7QB^(?_  4:_9:^*'@WP:VM>!?"&E? ^'Q%KJ^(/"FG
MC39- ^-OC;7M64Z9J^NV&LW?V32;^TN\V&G72S^;Y%J9KI)(4**_0_#/B?'\
M)\08K,\NHX.M7K9#G.6RAC:=:I15#'X7V-:<8T,1AIJK&+O2DZC@I:RIS6A^
M4^,7 N4>(7"F$R+.L1F.&PF'XEX?SJ%3*ZV&H8AXK*<<L5AJ<IXK"8VF\/.H
MDJ\51C4E#2G5IOWC]V:R/$$,MQH.MV\*[YI](U*&),JN^26RF1%W.55=S,!E
MF"C.20,FBBO@*4G&K3DMXU(25]KJ2:N?J56*G2JP=[2ISB[;VE%IVO?77LS\
M:?\ @C/\!OBS\#/"7QQLOBIX2/A2YU_7O!%SH\9UWPSKGVV"RTK6H;J0/X:U
MK68[?R9)(U*W;6\C[P8E=5<K^UM%%?;^)G$>.XMXXS[B',:.$H8W,:N#G7I8
M&%:GA8.AEV#PL/90Q%?$UHITZ$92YZ]2\W)IJ+45^=>$'!N6>'_ASPSP?DU?
M'XG+,EP^-I86OF=7#UL=4CB,TQV-F\15PN%P6'G)5<3.,'3PU)*FH*2E)2G+
MX2_X*6_#WQC\5/V+?B_X#\ :*WB'Q9KES\-CI>DKJ&DZ4;E=+^*_@?6;]OMV
MN7^F:9"+?3=/O+G%Q>Q&7RO)@$L\D43Z'_!.;P)XM^&G[&_P=\$>.M&?0/%.
MA6WBR#5=)>_TK4VM7F\<^);JW/V[1+_4],G6>UG@N$-O>RE$E6.813K+#&45
MM_K+CGX5KA#V.$_LV/'T^(U7]G6^O_79</TLM='VGUCZO]4]A!34/JOMO;7E
M[?D_=G/_ *E96O&A^(GUC,/[:EX9QX,>$]KAO[*>5PXGEG<<1[#ZI]<_M!8J
M<J?M5COJSP[Y'A'52K+\M_\ @H%\(/VHE_;Z\)?M"_ ;X=:=XKD\ ^%/ %UH
MM[K.O^#[32'\0:+-K\LMKJ&D:OXQ\-:O<6T<=]"7,+6R2[\171*.!K?\-<?\
M%B?^B"?!#_O[X4_^?U117[)EG'E+'<-<*8#.N!N!.(/[!R'!93E^,SK*\TQ.
M-A@J2=2-.=2EG>'IN]2<YRY*-./-.345I;\&S3PEJ9=Q=QOF_#OB;XH\)OBO
MBC'\09OEW#N=9!A,MGF5?V=&=6E1Q7#&,KQ2HT*5**J8FK+D@DYRW#_AKC_@
ML3_T03X(?]_?"G_S^J_6_P#8_P#'7QU^(GP3TGQ+^T;X;\.^%/BE-KGB.TU3
M1O"QM#I$.FV>I21Z++&;'Q)XLMC//IWDR7&S69OWI.Z&W;,2E%?%>(F<Y5F&
M04Z&"X'X*X<K1S'#U7C^'LMS#"8Z<(T<3&6&G5Q6:XVF\/4<XU*D%14W.E2:
MJ147&7Z'X6\+9UDO$M3%YAXF>)'%]">5XJ@LKXMS?)L=EE.I*KA9QQD*.7\/
MY776+I*E*G2J/$2IQIUZZE2E*490_,+]E_\ 9]^,7A+_ (*H?'3XO^(_!CZ9
M\.O$MQ\8%T3Q$WB#PG>"^&L:QI$^F,-(T[7KS7;9;R"TFE7[9I=NT*A5NE@E
M81U^[M%%?)>)'$V/XIS7)<9F%'"4:N!X4R+)Z,<%3KTZ<L-EM*K2H5*BKXC$
MR=><6W5E&<*<I?!2IK0^R\(^"LKX%R7B'+<IQ&88FAFG&W$G$>(GF57#5JT<
M=G5>CB<72HRPN$P<(X6%16P].=.I5A'2I7JO4_+_ /X*<_L.VO[5?PM_X33P
M59VEM\<_A?IU[>>%;MYK>P'B_P .1^9>ZIX#U/4+F:VM8#-('U+PQJ&H3);Z
M5K0FMWN;#3M<UB[7;_9"^-O[24/[,7BJ/X__  QU*[^,?P>\.W$.C2+XL\$:
MG-\7K.WTV<^%IKS4]/\ $US8:1XDN+RV30O$%WK5[:6MW(D/B,WOF:A?6M@4
M5[&6<5X[-^ :/!^<X3+\VRS(,^P>.R+$8V&+_M+*(8_%X>&89;@L7A\9A^3*
M\>G4EB,)4I5?WE3VU&I2JTL-.AXF9^'V4Y'XGXSQ%X?Q^;9#G?%/#.+RKB?!
MY;4R^.2\05,LPM>>4YQF> Q66XJ53/,JO"&#S"EB*+5"DL-B*5?#U\72Q'SU
M_P $J?V5/B=X*\4?&S]IK]HK2_L_QC^(6OZCH.G"ZU70-;N8],U.XL?%?B_Q
M"+CPYJFKZ7;-XCUVYLM.M[47$5Y86?AZ>%((+"_C$_[5445\YXC<49GQ?Q?F
MF<YHL-2K2>'P=#"X&E.A@,#@L!AJ6%PN#P.'G5K.AAZ5*FFJ?M)WJ3J5&W*<
MF?4>$W ^3>'G F3<-9'+&U\-2>-Q^)Q^9UJ>*S7,\QS3&U\=CLQS/%TJ&&CB
ML9B*]:2E5]C3M2A2I1BH4XI%?@CJ/[//QF_99_X*?Q?&GX.^#I-;^!?Q9N4U
M#XA66E:_X1TF/2]-^(T]U8>,M/ETC7=>TW4[HZ!XVTZ#XD:<FBV)A>U-GH-B
M[LE[9DHKO\-^)\?D&,X@P.'HX/&9?Q/PWF.19QE^84ZU7"8C"8A0E&M&%#$8
M:=/'82I'VF"Q4*G/AIRFXI\\D_/\6.!LIXPPG">88W$9CE^:\%<8Y/Q5P_FN
M45Z&&QV%S#!2J0EAYSQ&%Q=*OEF84:CH9G@*E%TL92C",VG3A)>T_P#!8[X)
M_$_XX?"/X1Z#\+?"[>*M6TCXD:AJVHV@UKP[HGV;3V\*ZG9"X\_Q)J^CVTV;
MFYAC\J":6?YBYCV*S#]0?A#IM]HOPF^%^CZI;FTU/2?AWX*TS4;4RP3FVOK#
MPUIEK=VYFM99[:8PW$4D9EMYIH)-N^*62,JY**PSCB7'8WP]X-X9JT<)' 9)
MF7$.,PE:G3K+&5*N9XBE.O'$5)8B="=.#IQ]BJ>'I2BF^>=32VV0<&97EGBK
MQ_QM0KX^>:\49/PKEN88>M5P\LOHT,BPU6&#G@Z4,+3Q-.K46)J?6)5L7B(3
M:C[.%))I^B4445^?GZD?@/\ \%4?@E^T)XT_:<^ ?Q6^"7@.W\62_#/PWHFL
MP7%]K_A+3+"'Q+X=\>W/B33+2^L->\4>'K^]M'DM;5[H6;(DD#O"EY#,28\C
M_AKC_@L3_P!$$^"'_?WPI_\ /ZHHK^GL@X[IXCA#A7)\XX*X'XBH</Y?7P>6
MXG/,LS3%8RE0Q&,JXFM&52CG6&I>_5EKR4::M&.EU=_Q_P 2>%$L/QYQMQ)P
M_P")/B;PCBN+<TPF8YU@N&<YR+!Y=6Q6#R_#X'#SA1Q?#6.KKDP])17M,34=
MYS]ZS48G_#7'_!8G_H@GP0_[^^%/_G]5^H7[$/Q(_:9^)OPT\2ZU^U+X0\*>
M#/'%EXWN]+T33?"+:<VGW'A>/0]"NK>]G.F^+_&</VM]4N]5A;?J5O)Y,$.;
M)%VSSE%?,\?9WE&/X<KX?!\!\#Y!7>)PLEF.0Y7F.%S"$8U%S4H5L3F^,I*G
M57NU8N@W*.BE'<^O\->$L\RCBK#8W'>*7B=Q7AX87&TY9/Q1G.28W*:LJE!Q
MC6JT,#P[EN(E6H->TH2CBHQC4UE":T/%/^"B'_!//3OVPM*T7QKX'UC3O!?Q
MS\$V,ECH>N:@ES'H_BS1(Y)[ZT\,>(;NP62^TQK#5)I+[0?$-K;7\VDR7>I0
M2Z?=PWR2V'Y?7_[?/_!2/]C*TM_AW\=O"7@+QO\ V$HTVRU[QC?:;K7B6\@\
MS[+8-=>(?!/B]/[51/**QWFM:-_;5RI\W5[R:X)<E%?9> ?$,^-,?E7A?QEE
M.2<5<+818C$Y3'.L#.OF>1^UJ0]M0RG,J->A7P^&KRFYSHU/;13C"-/V=.$8
M+\L^E/PE3\.LGXC\;_#S/^)>!N.<51H4,\EPYF5+#9+Q,\+2?U3$<09-B<)B
M\+C,7AHTE3IXFDL-4G"=7V[JSJ3F[K^%?^"CW_!4A=.TGQQK/@[X3?L]MJ%G
MJ=\FBS:-%X=\RT>1K:YD\.:9X@UGQWXQU>(2"XLM,\2ZOIGAB.\M8+V)M*OH
MHKAOZ!OV?_@3X$_9M^$_A3X/_#FUN8?#GA>VGS>:A*MSJ^N:MJ%S+?:SK^LW
M2)&L^I:KJ$\US*(HX;2TB,&G:=;VFFV=G:0%%? ^,/&>98O,\5P%@L%D_#_!
M_#.;5Y9?D'#V 678*MC8P=%YIF-ZM:MCLRE1E*F\17JM1C*HZ=.$JM64_P!4
M^C_X<9-EN48'Q1S',>(>+?$+C/(,''-N+.+<UEF^:4,MJNGC/[#RGEHX;"Y5
MDM/$QC6C@L)AH.4H4E6JU8T:,:?LU?C?_P %DO@A\4?CC\+?@]HWPM\+'Q3J
M>B^/=<U/4[4:UX<T3[-8R^&9K1+CSO$FKZ/;S9N)$C\JWFEF&=YCV L"BOC/
M#7B#&\*\<</\09?2PM;&9;B:]6A2QL*M3"SE4P.*H-5H4*V'JRBH59-*%:F^
M91;;2:?Z3XN<(Y;QYX<\3\(YQ6QV'RW.\+A<-BZV6U*%''4Z=/,L%B8O#U<3
MAL90A/VE"";J8:K'D<DHIM27ZI?"G3KS1_A=\-M)U&'[/J&E^ ?!VG7UOYD4
MWD7EEX>TZVNH?-@>6"7RIXG3S(9)(GV[HW="&/?445\=BZLJV+Q5:22E5Q%:
MK)1345*I4E)J*;;23>EVW;=L^]P-.-'!8.C%MQI87#THN5G)QITH03DTDFVE
MK9)7V2V/PN^%WP)^*VF_\%A/B/\ &6]\*&#X:ZBOBP67B7^W/#4@G-S\-M(T
MF ?V/#K,GB",OJ$$UO\ OM*C"[/-<K R2-^Z-%%?>>(_$6-XCQ?"U7'4L+2E
ME/ W#>0X986%:"G@\LHUX4*E?VU>NY8F:F_;3ING2DTN2C35T_S'PCX1RW@_
M <:T<LKXZO'/_$GBWBK&/'5*%65/,<\K86MBZ.&>'PV&4,'3G32P].JJU>$6
MU4Q%5V:_#C]K7_@EQXRM_B7<?M,_L/>+O^%8_%&'4+GQ'J'@6VU.3PU97NO7
M<LDNJ:GX+U])%L=";6%GN%U?PEK4 \*:HL]S$;K3;&>?3[CX[\0?\%8/V^?@
M)+/\._C'X#^$VI>.+.(6<>KZOIT)U)KBV9H;B\U./X?^,5\+7L\LCQ$IIEOH
MMHI0^7;A7.THK^C? +.X^+.8TN#/$?)<AXOP6094YY3FV;8"53B/"8>A)>RR
M_P#MBC7HUJ^ @U?V6)A6J3ORSK2@HQ7\>?2MX;GX"Y%C?$KP>XCXHX S3B;.
MH4\^R'(<UC3X/S'&8U-8C-Y</8G#8C#X7-9QM%8C U,+3@[U(4(U92J2W]/^
M&?\ P4B_X*>PZ</BCXU\,_"WX 37EEJ%U;Z1-H\'AV41NTT,UGX)\.:UJ?B;
MQ;JEK+"D]E;>.]?L=.L[A8[JSO;6=#G]U/!'[*7PR\"_LSG]E;3+CQ=)\.[G
MP?K'A#5+]O%6L0>)[Z/Q'%<GQ#J4&KP72MI,VJ7M[>WS:5I<5MX=M_M4VG1:
M/_9$LUA*45^.>*W'^=U\ZJ\(9;0RKAGACA#/:N(R;)>&,OAE.$AF6&?)3SC$
MN$ZN(Q6:<O\ S$U:S4).<Z5.G*I5E/\ HGP-\*>&L%P]1X^SC%9]QIQKQ_PO
MAL+Q%Q)QKFU3/<PJY/C8*O5X>P<9TJ&#P&1JI+_<L/A82JQC3CB:U>-&BH?C
M-<?LB_\ !0S_ ()]:SJVL_LD_$C3OBG\%[J^GU2[\&>)+SP]90P0K<.\<'B+
MPEXNU'3-)AOY+5H8KWQ/\/-?T75]:>V<W-KI5NMK9'(7_@I[_P %#?$E[/X
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'4Z4(043_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140409493436960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Aug. 06, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug.  06,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-51173<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Gyre Therapeutics, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001124105<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">56-2020050<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">12770 High Bluff Drive<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 150<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">619<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">949-3681<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">GYRE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$
MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7<K_WUE[O)I#-ZG7TZSFN4
M?VFK :?MNYO/D_QSZ.2?IY/734+.<+PL"?'[(UMAAR=N.Q-R.AQG0GS/]O:1
MI24RS^_Y"NM./&<?5I:P7<_/Y)Z,<B.[W?98??9/1VXCUZG LR+7E$8D19_(
M+;KD$3BU20TR$S\(G8:8:E < J0),9:AAOBTQJP1X!-]M[X(R-^-B/>K;YH]
M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M
MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZ<TT#PE"\D^DJ1CVFS(Z=T)LWH
M,QK!1J\;=8=HTCQZ_@7YG#4*')$;'0)G&[-&(81IN_ >KR2.FJW"$2M"/F(9
M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+
MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T
M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MT*E7L'5]DZ7"AY&#A9N!?@5G_.,/O.?^0O"U2[XVI5XE<+E+H0Z.#K^^_$Q
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MY?.J>ZC+N.HL?X;[:)'-M[#/)73)>UYN1]76^T$D7O!9QP<<GB-WPQ-',)^
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M-_=%KLWC":[?#'!X=/X!4$L#!!0    ( -2!"%EED'F2&0$  ,\#   3
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M  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #4@0A9)!Z;HJT   #X 0
M&@              @ ',$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-0
M2P$"% ,4    " #4@0A999!YDAD!  #/ P  $P              @ &Q$@
I6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  #[$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.2.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ef20033805_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ef20033805_8k.htm">ef20033805_8k.htm</File>
    <File>gyre-20240806.xsd</File>
    <File>gyre-20240806_lab.xml</File>
    <File>gyre-20240806_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ef20033805_8k.htm": {
   "nsprefix": "gyre",
   "nsuri": "http://ir.catalystbiosciences.com/20240806",
   "dts": {
    "inline": {
     "local": [
      "ef20033805_8k.htm"
     ]
    },
    "schema": {
     "local": [
      "gyre-20240806.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/currency/2023/currency-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/exch/2023/exch-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd",
      "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "gyre-20240806_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "gyre-20240806_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 29,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "report": {
    "R1": {
     "role": "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation",
     "longName": "000100 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c20240806to20240806",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20033805_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20240806to20240806",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20033805_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://ir.catalystbiosciences.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001140361-24-036404-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-24-036404-xbrl.zip
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M]:%KX)#ODB_I)7(K4N$4$EK-0B54S9ZZ.@52"W_H.[BQFKH^+Y#1>)RQ,\A
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M]$+S "_@KI$7]G6;V>_:+_KQ=<'-8CQ3_-UM^:F8TM]A/HKW_A]02P,$%
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M=3Y+M1IK'AN8*? LJ1+&V91K*>R<O!5,M,(ZIO28)RR41G C#'DTY'/&<R2
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M\D 4?Q%2>G5',OC_DNC,]42:9@>Z=+%<" -\ZBAK2&=E"RJ;>O&+N[88Q)Q
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MKE*]0D.UWLW!.?O$W]I:-R756TYG_P-02P,$%     @ U($(6;X0^K_H!0
M#3\  !4   !G>7)E+3(P,C0P.# V7W!R92YX;6S56UUOXC@4?5]I_T.6?89
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MD&H';T#M&Y*%*/X;(W;#MV06O2TH3?$*"J[F[H(:JEY)(G7OOQG=#[ZM5]Z
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MJY[^*)P3(]?)@H$G?9-B:D2WI%!R0^YX36E,0I)SKWY#.68$Z9=E=H ZPAL
M\%2N+:/NZ&X8K_2%W.>:,"QL*=[#*=Z@$._NL+O%HG*?7 ^4"^4"PM.]<5DU
M^KOR*!] [G-I_$=9ML&LL1NL<+,G#'#PSJ@K\31_&+(IESRWEW;I5Y9PS#>(
M5](/$?%'O,+]X7]02P$"% ,4    " #4@0A9G3>\Y P8  #DE   $0
M        @ $     968R,# S,S@P-5\X:RYH=&U02P$"% ,4    " #4@0A9
M,O&77,0-  !2)@  %0              @ $[&   968R,# S,S@P-5]E>#DY
M+3$N:'1M4$L! A0#%     @ U($(64D$H?=. P  8P\  !$
M ( !,B8  &=Y<F4M,C R-# X,#8N>'-D4$L! A0#%     @ U($(67I>/:%[
M"   ,%8  !4              ( !KRD  &=Y<F4M,C R-# X,#9?;&%B+GAM
M;%!+ 0(4 Q0    ( -2!"%F^$/J_Z 4   T_   5              "  5TR
M  !G>7)E+3(P,C0P.# V7W!R92YX;6Q02P4&      4 !0!' 0  >#@

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>ef20033805_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="gyre-20240806.xsd" xlink:type="simple"/>
    <context id="c20240806to20240806">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001124105</identifier>
        </entity>
        <period>
            <startDate>2024-08-06</startDate>
            <endDate>2024-08-06</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20240806to20240806"
      id="Fact_ac35e0de7f314a7bbe8ec32436c8b888">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20240806to20240806"
      id="Fact_aba2505f229648b989bdd47d4d1785ad">0001124105</dei:EntityCentralIndexKey>
    <dei:SecurityExchangeName
      contextRef="c20240806to20240806"
      id="Fact_a48ae1d2275e4cb08bfd46c5efcde35b">NASDAQ</dei:SecurityExchangeName>
    <dei:DocumentType
      contextRef="c20240806to20240806"
      id="Fact_d4bcfa713a6244d3870d8a0c1d49e8ec">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20240806to20240806"
      id="Fact_481c5670179d4a668ea4f0446e1015e8">2024-08-06</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20240806to20240806"
      id="Fact_ddfafff6c463426cbead8059ea0e0587">Gyre Therapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20240806to20240806"
      id="Fact_611f35cbf21546f69be1b60b814a179f">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20240806to20240806"
      id="Fact_4a2d6c0219384a5da162b253edc867c7">000-51173</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20240806to20240806"
      id="Fact_fabad11441cc47feb521a82080a95bba">56-2020050</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20240806to20240806"
      id="Fact_5f41171208514f7ba99948bee88a2a90">12770 High Bluff Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="c20240806to20240806"
      id="Fact_c6b50b2050bd41e6848813273234bb89">Suite 150</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="c20240806to20240806"
      id="Fact_af36167fe088425f8d453a4358809f15">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20240806to20240806"
      id="Fact_521cd7eedebc4c9980c6c3ddbe08e47a">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20240806to20240806"
      id="Fact_7d0528ba37c54ca99eaaca60f1962972">92130</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20240806to20240806"
      id="Fact_ddcc513b8d604fb1a3bf00ca5b7e4df2">619</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20240806to20240806"
      id="Fact_bb89480ce0904a68bab8799f80fd4fed">949-3681</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20240806to20240806"
      id="Fact_e0159aa2fe4f4ece96a564c03c48afed">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20240806to20240806"
      id="Fact_3039ddab98314cabb99f3046336ab7ee">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20240806to20240806"
      id="Fact_1b883be29c59427c9a0805c407889202">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20240806to20240806"
      id="Fact_4ab3b09267904dc78f40ce0dc2cdd0d2">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20240806to20240806"
      id="Fact_501596c5f0d34a489a8ebc52c5c0b24c">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20240806to20240806"
      id="Fact_82ec86713e0c4eefba3433ee6e35e9c5">GYRE</dei:TradingSymbol>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20240806to20240806"
      id="Fact_afaed60caf1647e7a94c82013b657f0f">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
